Press Releases Archive

New Bicoll homepage

Modern design and navigation improve the customer experience Planegg / Martinsried (Germany) – December, 11th, 2017 – Today, Bicoll Group has launched a newly designed and now, mobile optimized, company website at www.bicoll-group.com. In addition to our technology and products, publications, event and latest news, it features convenient links to our LinkedIn and Twitter presence. …

Bicoll moves in to the leading European biotech cluster

The biopharmaceutical company is now one of the 62 start-up companies in the Innovation Center for Biotechnology in Martinsried near Munich. Planegg / Martinsried (Germany) – June 9, 2016 – Today, Bicoll Group announced that it has been selected by the Fördergesellschaft IZB mbH which operates the Innovation and Start-Up Center for Biotechnology (IZB) to …

40.000 historic formulations as starting point for new drugs

Research project EPICLEAP receives partial funding from the German Federal Ministry of Education and Research March 12, 2014 – BICOLL Group, Munich/ Germany and Shanghai/ PR China and the Horst-Görtz-Endowment Institute for the Theory, History and Ethics of Chinese Life Sciences, Charité – Universitätsmedizin Berlin, have announced today to receive a partial funding from the …

Bicoll receives first payment as member of the €11.5 million EU funded EpimiRNA project to develop novel epilepsy therapeutics

Munich (Germany) – October 29, 2013 – BICOLL Group announces today to receive the first payment as participant and work package leader in the EpimiRNA consortium. Recently the whole consortium was granted up to €11.5 Million funding by the European Union over the next five years. BICOLL is responsible for the consortium’s small molecule drug …

German Business Delegation visits Bicoll Biotechnolgy (Shanghai) Co. Ltd.

Life Science Experts got exclusive insights into the first Sino-German Biotechnology set-up in Shanghai/ P.R. China. The German Federal Ministry of Education and Research (BMBF) and its Chinese Counterpart (Ministry of Science and Technology of the People’s Republic of China (MoST) have organized a delegation’s official visit for life science experts to China from August …

Innovative Fragment Library Concept Allows Identification of New Lead Compounds for Immediate Pre-Clinical Use; Bicoll and Crelux to Market Co-Developed New Fragment Service Platform

Munich (Germany) – December 7, 2011 – BICOLL announced today that it has entered into a sales agreement with CRELUX, a high quality protein and crystallography service provider. The two companies will jointly market their new platform technology to identify a broad range of small active bio-molecules for further (pre-)clinical development. CRELUX will base the …

Bicoll and Naturalpha announce Nutraceutical Research Alliance; European-Funded Research Cooperation Olnorme II Extended

Munich, Germany – July 20, 2011 – Bicoll GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry and medicinal chemistry to identify novel small molecules for drug discovery and related innovative fields, and Naturalpha, international consulting, scientific and clinical research company in nutrition and health, partner of food and pharmaceutical industries announced …

Bicoll as Partner of a € 2.7 M European-Funded Euro TransBio Program; Olnorme II Program Focuses on the Development of a New Class of Drug Candidates for the Prevention and Treatment of Cardio Metabolic Diseases with an Inflammatory Component

Munich, Germany – May 11, 2011 – BICOLL GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry and medicinal chemistry to identify novel small molecules for drug discovery and related innovative fields, will be responsible for roughly 1 Million Euro of the project volume. As part of the EuroTransBio initiative, the German …

Bicoll and the European Molecular Biology Laboratory (EMBL) announce results of their joint research project on the identification of aurora kinase inhibitors

Munich (Germany), Heidelberg (Germany) – June 22, 2010 – BICOLL GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry to identify novel small molecules for drug discovery and related innovative fields and EMBL, the renowned international and inter-governmental research organisation, focusing on molecular biology and biophysics, today announce the successful completion of …